leadf
logo-loader
viewNext Green Wave

Next Green Wave achieves operational milestones for Intrexon's Botticelli cannabis plantlet production

CEO Michael Jennings said the research facility opening is a “huge milestone” in the company’s path to establishing a world-class cannabis nursery

Next Green Wave - Next Green Wave achieves operational milestones for Intrexon's Botticelli cannabis plantlet production
The Botticelli laboratory at the Next Green Wave facility

Next Green Wave Holdings Inc (CSE:NGW) (OTCMKTS:NXGWF) said Tuesday that it has completed the installation and activation of its research and innovation laboratory under license from biotech leader Intrexon Corp (NASDAQ:XON).

In a statement, the Vancouver-based cannabis company said this will advance Intrexon's Botticelli next-generation non-GMO propagation platform and begin the rapid optimization and production of Next Green Wave's proprietary cannabis cultivars.

READ: Next Green Wave hits key milestone with successful cannabis harvest

In line with a deal announced on March 22, Intrexon and Next Green Wave have now achieved the following milestones:

  • Optimization of the Botticelli protocol for Next Green Wave's hemp CBD strains; and
  • Achieved the completion of a tissue culture lab at a Next Green Wave production site to begin Botticelli optimization of the cannabis company’s proprietary nursery stock

In a statement, Next Green Wave CEO Michael Jennings said the opening of the research facility is a “huge milestone” in the company’s path to establishing “a world-class” cannabis nursery.

“Combining Intrexon's proprietary Botticelli tissue culture platform with Next Green Wave’s proprietary stock and cultivation team, we aim to push the limits of the current cannabis performance paradigm,” said Jennings.

“After a successful optimization phase, we will begin the Botticelli plantlet production for our own internal cultivation and also supply our industry leading plantlets to other licensed cultivators in California," he added.

The company noted that in the US market, legal cannabis revenue is projected to exceed $31.3 billion by 2022, with California representing around a third of that market. Current cannabis cultivation is predominantly dependent on clonal propagation by using cuttings of mother plants. This creates barriers to meeting product demand and also the risk of disease susceptibility. In addition, plants derived from repeated cuttings lose their vigor in performance.

Given these drawbacks, the company noted that Botticelli offers the potential for a “sustainable, scalable, and more economical solution” than conventional clones.

"We are excited to have achieved optimization of Botticelli protocol for hemp CBD strains, as a proxy for cannabis, and feel confident about the potential of our platform for cannabis cultivation,” said Sekhar Boddupalli, president of Intrexon's Ag Bio Division.

“We are looking forward to seeing the Botticelli platform enabled and integrated with Next Green Wave's production, validating its value-add for the cannabis industry," he added.

Nursery production

On a separate note, Next Green Wave announced that its current nursery production, derived using traditional cloning methods, has reached inventory levels sufficient to begin sales to other retail and licensed producers.

The nursery has the capacity to produce up to 80,000 plantlets per month to fulfill both internal use and external sales. Additionally, the company has now completed its second harvest of a variety of premium cannabis flower and entered a perpetual cycle to harvest two rooms every 10-to-14 days.

Operating in California, the world’s largest cannabis market, the Vancouver-based company has an ace in its back pocket that many don’t – it is fully-licensed to conduct operations across the entire value chain: nursery, cultivation, extraction and distribution.

Next Green Wave’s indoor cannabis facility in Coalinga, California is nestled about halfway between Los Angeles and San Francisco. The company is currently expanding operations on its cannabis zoned property. It has a seed library of over 120 strains and is developing its nursery cloning operations with biotech leader Intrexon.

— Adds company and nursery production details — 

Contact Uttara Choudhury at uttara@proactiveinvestors.com

Follow her on Twitter: @UttaraProactive 

Quick facts: Next Green Wave

Price: 0.38 CAD

CSE:NGW
Market: CSE
Market Cap: $60.61 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Next Green Wave named herein, including the promotion by the Company of Next Green Wave in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Next Green Wave continues to show management plan is working with more...

Next Green Wave (CSE: NGW- OTCQX: NXGWF) CEO Michael Jennings joined Steve Darling from Proactive with news the company continues to see positive cash flow, EBIDTA, and net income. Jennings talks about the last 7 months and how they continue to execute on their original business...

1 week, 2 days ago

3 min read